Autopsy report · NCT03400852

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy

“Slow enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 44 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Mallinckrodt ARD LLC

Sponsor type

Industry

Conditions

Muscular Dystrophy, Duchenne

Interventions

MNK-1411; Placebo

Participants

44

Sites

16

Countries

Bulgaria, Israel, Italy, Mexico, Serbia, Spain, Turkey (Türkiye), United States

Trials that died the same way

• EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study
  “too slow enrollment” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.